San Antonio activists, city leaders and community members joined a national call to action on protecting voters’ rights at a rally on Saturday at MLK Plaza.
“There is no more fundamental problem in our nation and in our local communities than protecting people’s voting rights and access to the ballot boxes,” San Antonio Mayor Ron Nirenberg said at the rally. March on for Voting Rights. “When it’s eroded as it has been by state law, that’s a reason for anyone to be concerned.”
A year after Haryana Forestry Minister Kanwar Pal said the government would build a 100-acre biodiversity park at Kasan in Manesar, the district administration said on Friday that Manesar Municipality and the Department forests would sign an agreement to develop the project.
A year after Haryana Forestry Minister Kanwar Pal said the government would build a 100-acre biodiversity park at Kasan in Manesar, the district administration said on Friday that Manesar Municipality and the Department forests would sign an agreement to develop the project.
This was announced by Gurugram deputy commissioner Yash Garg, who was chairing a review of projects undertaken by the GuruJal company.
Narendra Sarwan, member secretary of the GuruJal company, said Garg had given instructions to agents from both agencies and asked them to sign a Memorandum of Understanding (MoU) to this effect soon.
On August 16 of last year, Minister Pal said, “The park will benefit from the support and participation of the local community, especially since the panchayat lands are used for this. This will help restore green cover in the area, raise the level of groundwater, and also generate income for the local community.
During the review meeting, Garg also called on departments to coordinate with each other to expedite work on projects delayed due to the Covid-19 pandemic. “All departments should aim to complete the 60 projects decided in January by December 31,” Garg said.
These projects mainly include the development of ponds and water bodies across the district and how different departments would finance these projects.
During the meeting, the issue of housing companies not setting up rainwater harvesting structures was also discussed. The administration said it would seek clarification from the affected residents’ welfare association in this regard.
The Deputy Commissioner was also informed that the Municipality of Gurugram has launched the tendering process for the construction of 230 additional rainwater harvesting structures in the district. At present, the company has put in place 403 of these structures, of which 60% of the clean-up work has been completed, said Sarwan.
Receive our daily newsletter
Thank you for subscribing to our daily newsletter.
After three weeks of unrest in the Pacific Grove Unified School District over old racist social media posts featuring the president of the PG high school student body, who resigned on August 19, district officials have issued a statement in response to the situation and offered to incorporate lessons in equity and diversity throughout District K-12.
“We are supporters of diversity, equity and inclusion, and we strongly oppose racism, bullying and supremacy in all their forms,” the statement said. “As a high school community, in particular, we need healing. We will work with staff, students and families over the weeks, months and beyond to ensure we continue to develop a culture where everyone knows they belong. “
The letter, addressed to the “PGUSD community,” was emailed on August 23 and posted under the announcements on the district website. It is signed by Superintendent Ralph Porras and PGHS Director Lito Garcia.
“Recent events in our school community have exposed issues that challenge the work we have done to foster a culture of equity and inclusion at the district level,” the letter opens. “The events themselves and the issues that have surfaced are sensitive and call for a deliberative process that we must all engage in so that we can begin to heal.
“We need to first think about what brought us to this point of restlessness, and then start to overcome the pain together so that we can eventually achieve a positive outcome for all of our school population, as well as for the students that we have. we serve. “
The “recent events” began with a Change.org petition launched on August 7 by Alexandra Ulwelling, junior of PGHS, calling for a recall of ASB president Anthony Biondi after the publication of social media posts describing him in the process of uttering the N word in a classroom in 2019 and a year later selfies of him holding a Confederate flag and dummy weapons. The posts were deleted, but not before other PGHS students saw and copied the posts.
Biondi was elected ASB president in May, and soon after, the video was made anonymous. Garcia emailed the families on May 28 outlining the administration’s response in general terms, without naming Biondi or going into exact details of the disciplinary action taken. (By law, student discipline is confidential.)
Ulwelling told the Weekly recently in August, she was waiting to see if Biondi would still hold a managerial position. When it became apparent after the start of the school year on August 5 that he would still be president, she created the petition which was signed by more than 625 people. (The petition was closed after Biondi resigned.)
As more people signed the petition and pressure mounted from community members, Biondi resigned on August 19, the same day as a regular PGUSD board meeting. He attended the meeting and read his resignation letter.
Three of the administrators and Porras – while not approving his actions – congratulated Biondi for coming and expressed frustration at communications from residents angry with the district for not taking stronger action and preventing Biondi from coming. become president. In turn, some community members said the district failed to protect other students who may have been hurt by the messages.
“We’re talking about how it affected him, but how did it affect all of the students of color who saw this video? Asked a young black woman. “We can say it’s great that he’s come here and talked, but he forced himself these actions, and lift him up and say ‘go ahead, I’m so happy for you’, that is a little insulting. “
Only one administrator, Carolyn Swanson, has called on the district to create new student policies and initiate equity and tolerance training for district council and staff.
In the letter, Porras and Garcia said they “intend to incorporate lessons about diversity and equity into all facets of our school community so that the transformation we collectively undergo becomes tangible.”
They said introspection is needed to “learn to identify our own weaknesses and begin to address them in a thoughtful, honest and process-oriented way.” They said the effort would start with staff, then students and eventually community members, and that they would reach out to “community partners” for resources and support.
The large shareholder groups of Talis Biomedical Corporation (NASDAQ: TLIS) have power over the company. Generally speaking, as a business grows, institutions increase their participation. Conversely, insiders often decrease their ownership over time. I generally like to see some degree of insider ownership, even if it’s just a little. As Nassim Nicholas Taleb said, “Don’t tell me what you think, tell me what you have in your wallet.
Talis Biomedical is not a large company by global standards. It has a market cap of US $ 212 million, which means it wouldn’t get the attention of many institutional investors. In the graphic below, we can see that the institutions are visible on the share register. We can zoom in on the different property groups, to find out more about Talis Biomedical.
Check out our latest review for Talis Biomedical
What does institutional ownership tell us about Talis Biomedical?
Institutional investors typically compare their own returns to the returns of a commonly tracked index. They therefore generally consider buying larger companies that are included in the relevant benchmark.
Talis Biomedical already has establishments registered in the share register. Indeed, they hold a respectable stake in the company. This may indicate that the company has a certain degree of credibility in the investment community. However, it’s best to beware of relying on the so-called validation that comes with institutional investors. They too are sometimes wrong. If several institutions change their mind about a stock at the same time, you could see the stock price drop quickly. So it’s worth checking out the Talis Biomedical benefit history below. Of course, the future is what really matters.
Our data indicates that hedge funds own 52% of Talis Biomedical. This catches my attention as hedge funds sometimes try to influence management or make changes that will create short-term shareholder value. The company’s largest shareholder is Baker Bros. Advisors LP, with a 29% stake. ArrowMark Colorado Holdings, LLC is the second largest shareholder with 23% of the common stock, and Randal Scott owns approximately 6.7% of the company’s stock. Randal Scott, who is the third shareholder, also holds the title of member of the board of directors.
A more detailed study of the register of shareholders showed us that 2 of the main shareholders hold a considerable share of the ownership of the company, through their 52% stake.
Institutional ownership research is a good way to assess and filter the expected performance of a stock. The same can be achieved by studying the feelings of analysts. There are a lot of analysts covering the stock, so you can look at the expected growth quite easily.
Insider property of Talis Biomedical
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The management ultimately reports to the board of directors. However, it is not uncommon for managers to be board members, especially if they are founders or CEOs.
I generally consider insider ownership to be a good thing. However, there are times when it is more difficult for other shareholders to hold the board accountable for decisions.
Our most recent data indicates that insiders own a reasonable proportion of Talis Biomedical Corporation. It has a market capitalization of only US $ 212 million and insiders have shares worth US $ 22 million in their own name. It’s great to see insiders so invested in the business. It might be worth checking out if these insiders have bought recently.
General public property
The general public, with a 12% stake in the company, will not be easily ignored. While this property size may not be enough to influence a policy decision in their favor, they can still have a collective impact on company policies.
With a 6.0% stake, private equity firms are able to play a role in shaping corporate strategy with an emphasis on value creation. Sometimes we see private equity sticking around for the long haul, but generally they have a shorter investment horizon and – as the name suggests – don’t invest much in public companies. After a while, they may seek to sell and redeploy the capital elsewhere.
It’s always worth thinking about the different groups that own shares in a company. But to understand Talis Biomedical better, there are many other factors to consider. Consider, for example, the ever-present specter of investment risk. We have identified 2 warning signs with Talis Biomedical, and understanding them should be part of your investment process.
Ultimately the future is the most important. You can access this free analyst forecast report for the company.
NB: The figures in this article are calculated from data for the last twelve months, which refer to the 12-month period ending on the last date of the month of date of the financial statement. This may not be consistent with the figures in the annual report for the entire year.
If you decide to trade Talis Biomedical, use the cheapest platform * which is ranked # 1 overall by Barron’s, Interactive brokers. Trade stocks, options, futures, currencies, bonds and funds in 135 markets, all from one integrated account. Promoted
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell shares and does not take into account your goals or your financial situation. Our aim is to bring you long-term, targeted analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price sensitive companies or qualitative documents. Simply Wall St has no position in the mentioned stocks. *Interactive Brokers Ranked Least Expensive Broker By StockBrokers.com Online Annual Review 2020
Do you have any feedback on this item? Are you worried about the content?Get in touch with us directly. You can also send an email to the editorial team (at) simplywallst.com.
LONDON, Aug 25, 2021 (GLOBE NEWSWIRE) – Achilles Therapeutics plc (ACHL), a clinical-stage biopharmaceutical company that develops precision T-cell therapies to treat solid tumors, today announced that U.S. patent US 11 098121 and European patent EP3347039B have been granted. The patents cover a method of identifying cancer patients who may respond to a checkpoint inhibitor (CPI) by determining the total number of clonal neoantigens or the ratio of clonal and subclonal neoantigens in patients’ cancer cells. Clonal neoantigens are neoantigens present on all tumor cells and absent from healthy tissue.
Patents are based on data showing that patients with higher numbers of clonal neoantigens respond better to checkpoint inhibitor therapy1. These initial results were confirmed in subsequent studies showing that clonal tumor mutation burden was the strongest predictor of response to IPC in seven different tumor types and three different classes of IPC in over 1,000 patients. processed by IPC.2.
“This is another important step in building our intellectual property position around our precision T-cell therapy platform, supporting our approach to targeting the clonal neoantigens that we identify with our proprietary PELEUS.® bioinformatics platform, ”said Dr Iraj Ali, CEO of Achilles Therapeutics. “This adds to the growing body of data supporting our thesis that clonal neoantigens are the best targets in the treatment of solid tumors. Our technology allows us to prospectively identify and target all of a patient’s unique clonal neoantigens and develop neoantigen-reactive clonal T cells, or cNeT, and ensure that these reactivities are present in the final drug through to our power release test. “
Patents are assigned to Cancer Research Technology and licensed exclusively to Achilles in certain areas. The inventors include three of Achilles’ co-founders, Dr. Sergio Quezada, Scientific Director, Dr. Karl Peggs, Chief Medical Officer, and Professor Charles Swanton, Royal Society Napier Cancer Professor and Chief Clinician of Cancer Research UK, as well as Group Leader at Francis Crick Institute and UCL.
“Achilles continues to advance its development of precision T cell therapies for solid tumor cancers. These patents illustrate the pioneering work Achilles and Cancer Research UK have done in the area of clonal neoantigens, ”said Tony Hickson, business manager of Cancer research in the UK.
About Achilles Therapeutics Achilles is a clinical-stage biopharmaceutical company developing precision T-cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell. The Company has two ongoing Phase I / IIa trials, the CHIRON trial in patients with advanced non-small cell lung cancer (NSCLC) and the THETIS trial in patients with recurrent or metastatic melanoma. Achilles uses each patient’s DNA sequencing data, along with its proprietary PELEUS ™ bioinformatics platform, to identify patient-specific clonal neoantigens, then develop precision T-cell-based product candidates specifically targeting these patients. clonal neoantigens.
About the Cancer Research UK Business Partnerships team Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research. Cancer Research UK’s dedicated Business Partnerships team works closely with leading international cancer scientists and their institutes to protect intellectual property arising from their research and to establish links with business partners. Cancer Research UK’s business activity is conducted through Cancer Research Technology Ltd., a wholly owned subsidiary of Cancer Research UK. It is the legal entity that pursues research on drug discovery within the framework of thematic alliance partnerships and offers various commercial partnership agreements.
Forward-looking statements This press release contains express or implied forward-looking statements which are based on the beliefs and assumptions of our management and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our results, performances or achievements are materially different from the future results, performances or achievements expressed or implied by these forward-looking statements. The forward-looking statements contained in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will change our perspective. However, although we may choose to update these forward-looking statements at any time in the future, we currently have no intention of doing so, except to the extent required by applicable law. You should therefore not rely on these forward-looking statements as representing our opinions as of a date subsequent to the date of this press release.
More information :
Lee M. Stern – Vice-President, IR and External Communications +1 (332) 373-2634 [email protected]
Strategic communication of the Consilium Mary-Jane Elliott, Sukaina Virji, Melissa Gardiner +44 (0) 203 709 5000 [email protected]
Shares of Comerica Incorporated (NYSE: CMA) have received an average rating of “Hold” from the eighteen analysts who currently cover the company, reports Marketbeat Ratings. Three research analysts rated the stock with a sell rating, six issued a conservation rating, and eight gave the company a buy rating. The 1-year average price target among brokerage firms that issued stock ratings in the past year is $ 74.63.
CMA has been the subject of several recent research reports. Barclays raised its price target for Comerica shares from $ 74.00 to $ 77.00 and rated the stock “underweight” in a research note on Thursday, July 22. Truist Securities reduced its price target on Comerica from $ 100.00 to $ 83.00 and set a “buy” rating on the security in a research note on Thursday, July 22. Compass Point raised its price target for Comerica from $ 62.00 to $ 65.00 and gave the stock a “sell” rating in a report released on Tuesday, May 18. Citigroup assumed coverage of Comerica shares in a research note on Friday, July 16. They set a “buy” rating and a target price of $ 67.50 on the stock. Finally, Stephens lowered his price target for Comerica shares from $ 82.00 to $ 80.00 and established an “overweight” rating for the company in a report released on Friday August 6.
CMA shares opened at $ 73.65 on Wednesday. The company’s 50-day moving average is $ 70.33. The company has a market cap of $ 9.86 billion, a PE ratio of 9.59, a PEG ratio of 0.34 and a beta of 1.58. Comerica has a one-year minimum of $ 35.76 and a one-year maximum of $ 79.86. The company has a current ratio of 0.93, a quick ratio of 0.93, and a debt ratio of 0.38.
Comerica (NYSE: CMA) last released its results on Tuesday, July 20. The financial services provider reported earnings per share of $ 2.32 for the quarter, beating Thomson Reuters’ consensus estimate of $ 1.61 by $ 0.71. Comerica had a net margin of 37.02% and a return on equity of 14.51%. During the same period of the previous year, the company posted earnings of $ 0.80 per share. Stock analysts predict that Comerica will post earnings per share of 7.9 for the current year.
The explosive rise in tech stocks we saw in 2020 is just the start …
“The Earnings Whisperer” Louis Navellier posted a video detailing several key steps he believes every American should take right now.
Comerica announced that its board of directors authorized a share buyback plan on Tuesday April 27 which allows the company to buy back 10,000,000 outstanding shares. This buyback authorization allows the financial services provider to buy back shares of its capital through market purchases. Share buyback plans are often a sign that company management believes its shares are undervalued.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 1. Investors of record on Wednesday, September 15 will receive a dividend of $ 0.68 per share. The ex-dividend date for this dividend is Tuesday, September 14. This represents an annualized dividend of $ 2.72 and a return of 3.69%. Comerica’s dividend payout ratio is currently 83.18%.
Hedge funds have recently changed their holdings in the company. Lazard Asset Management LLC increased its stake in Comerica shares by 51.9% in the second quarter. Lazard Asset Management LLC now owns 395 shares of the financial services provider valued at $ 28,000 after buying 135 more shares in the last quarter. IFP Advisors Inc strengthened its position in Comerica shares by 275.9% during the second quarter. IFP Advisors Inc now owns 436 shares of the financial services provider valued at $ 31,000 after purchasing an additional 320 shares in the last quarter. Harvest Fund Management Co. Ltd. acquired a new position in Comerica shares during the 1st quarter valued at $ 31,000. Tobam acquired a new position in Comerica shares during the 1st quarter valued at $ 38,000. Finally, AGF Investments LLC increased its stake in Comerica shares by 69.9% in the first quarter. AGF Investments LLC now owns 576 shares of the financial services provider valued at $ 41,000 after purchasing an additional 237 shares last quarter. 78.26% of the shares are held by institutional investors and hedge funds.
Comerica, Inc. engages in the provision of financial services. It operates through the following segments: Commercial banking, Retail banking, Wealth management, Finance and others. The Commercial Banking segment involves middle market enterprises, multinational corporations and government entities by offering various products and services such as commercial loans and lines of credit, deposits, cash management, capital market products, international trade finance, letters of credit, trade management services and loan syndication services.
See also: What strategies should day traders use to execute a trade?
This instant news alert was powered by narrative science technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Comerica now?
Before you consider Comerica, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold … and Comerica was not on the list.
While Comerica currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better bets.
Time and attendance management software market by component (software and services), mode of deployment (cloud and on-premises), size of organization (large companies and SMEs) and vertical sector (BFSI, IT and telecommunications, healthcare Healthcare, Retail, Manufacturing, Government, Education and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
New York, August 25, 2021 (GLOBE NEWSWIRE) – Reportlinker.com Announces the Publication of the “Time and Attendance Software Market by Component, Mode of Deployment, Organization Size and Industry Vertical: Analysis of Global Opportunities and industry forecast, 2021 –2030 “- https://www.reportlinker.com/p06126682/?utm_source=GNW
Time and Attendance Management Software is a business application designed for tracking and optimizing the hours employees spend at work and for keeping records of wages and salaries paid. It is mainly used by HR departments and companies to simplify time tracking. These software solutions manage the company’s time and attendance data by automatically calculating all hours worked as well as vacation, sick days, statutory holidays and overtime. It is quickly used by businesses of all sizes. It provides management personnel with a variety of tools to help maximize cash flow and minimize waste. In addition, these software are designed for the generation, maintenance and archiving of important tax and salary information. Features of the time and attendance management software include tracking employee hours, complying with government regulations, tracking wages paid, tracking wages paid, and reducing accounting errors. Factors such as increasing need for employee efficiency and productivity and increasing transition to cloud-based time and attendance management software are primarily driving the growth of the global management software market. time and presence. In addition, the wide range of features and benefits of time and attendance management software, along with the massive adoption of automation tools in human resource management systems, are fueling the demand for management software. time and attendance. However, the security concerns and high installation costs associated with the software can hamper the growth of the market to some extent. On the other hand, increasing demand for time management and attendance software from small and medium-sized businesses is expected to provide lucrative opportunities for market growth during the forecast period. Furthermore, the ongoing technological advancements in the field of time and attendance systems are expected to be opportunistic for the market growth during the forecast period. The time and attendance management software market is segmented on the basis of component, mode of deployment, organization size, industry vertical, and region. By component, it is classified into software and services. By deployment mode, it is classified as local and cloud. Depending on the size of the organization, it is divided into large companies and SMEs. By vertical industry, it is divided into BFSI, IT & Telecommunications, Healthcare, Retail, Manufacturing, Government, and Others. Regarding the region, it is analyzed in North America, Europe, Asia-Pacific and LAMEA. The company profiles of the Time Clock Software Market players included in this report are KRONOS INCORPORATED, ULTIMATE SOFTWARE, ADP, LLC, WORKDAY INC., Ceridian, SAP SE, WorkForce Software, LLC, Oracle Corporation, IBM Corporation and Reflexis Systems .
KEY BENEFITS FOR STAKEHOLDERS • The study provides an in-depth analysis of the Time and Attendance Management Software market along with current trends and future estimates to elucidate impending pockets of investment. • Information on key drivers, restraints and opportunities and their analysis of impact on market size is provided in the report. • Porter’s Five Forces Analysis illustrates the power of buyers and suppliers operating in the industry. • The quantitative analysis of the Time and Attendance Management Software market for the period 2020-2027 is provided to determine the market potential.
KEY MARKET SEGMENTS
BY COMPONENT • Software • Services
BY DEPLOYMENT METHOD • On the site • Cloud
BY ORGANIZATION SIZE • Large companies • SMEs
BY INDUSTRY VERTICAL • BFSI • IT and Telecom • Health care • Retail • Manufacturing • Government • Others
BY REGION • North America o United States o Canada
• Europe UK o Germany o France o Rest of Europe
• Asia Pacific o China India Japan o Rest of Asia-Pacific
• LAMEA Latin America Middle East Africa
KEY MARKET PLAYERS • KRONOS INCORPORATED • ULTIMATE SOFTWARE • ADP, LLC • WORKDAY INC • Ceridian • SAP SE • WorkForce Software, LLC. • Oracle Corporation • IBM Corporation • Reflex Systems
Read the full report: https://www.reportlinker.com/p06126682/?utm_source=GNW
About Reportlinker ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
The United States Court of Appeals for the Sixth Circuit recently overturned a trial court order granting summary judgment in favor of the defendant over a consumer’s claim that the defendant had violated federal consumer law. fair debt collection practices.
In that decision, the Sixth Circuit held that while the defendant’s failure to properly identify himself in phone calls confused the plaintiff and led him to send a cease and desist request to the wrong entity, confusion in itself does not establish “prejudice for the purposes of Article III.
Therefore, the Court held that the consumer had not suffered “more than a mere procedural violation of the FDCPA” as required to establish the necessary standing to pursue his claims.
A copy of the notice in Ward v. Nat’l Patient Account Serv. is available on: Link to Opinion.
The consumer incurred medical expenses after treatment with a medical provider. The supplier hired a company to collect the debt. The collection company reportedly left several voicemail messages while attempting to collect the debt.
The consumer filed a complaint alleging claims against the collecting company (“defendant”) under the FDCPA resulting from the alleged voicemail messages where the defendant did not identify himself precisely. The consumer claimed that the defendant’s failure to accurately provide his correct legal name confused him. Due to this confusion, the consumer would have sent a cease and desist letter to the wrong entity.
Specifically, the consumer claimed that the defendant had violated Article 1692d (6) of the FDCPA, which provides that a “debt collector may not engage in any behavior the natural consequence of which is to harass, oppress or abuse any person in connection with the collection of a debt[,]”, Including“ making telephone calls without meaningful disclosure of caller ID ”.
The consumer also claimed that the defendant had violated section 1692e (14), which provides that a “debt collector may not use any false, deceptive or deceptive representation or means in connection with the collection of any debt.[,]”including” us[ing] any business, company or organization name other than the real name of the business, company or organization of the debt collector.
The defendant sought summary judgment arguing that he did not meet the definition of a debt collector under the FDCPA, and the trial court allowed the petition. This call followed.
On appeal, the respondent argued that the consumer lacked standing under Article III. Although the defendant did not raise this issue with the trial court, the Sixth Circuit observed that it had an independent obligation to determine its jurisdiction to hear an appeal.
As you may recall, standing requires that the “plaintiff must have (1) suffered prejudice in fact, (2) which is somewhat attributable to the contested conduct of the defendant, and (3) which is likely to be remedied by a Judicial Decision. “The onus is on the plaintiff to set out the facts which demonstrate standing.
The issue in this appeal was whether the plaintiff had suffered prejudice in fact. This requires that “the injury must be (1) specific and (2) concrete”. The dispute here revolved around the question of whether the consumer had suffered concrete damage.
The consumer claimed to have suffered concrete harm for two reasons. First, he argued that the violation of his procedural rights under the FDCPA established tangible harm. Second, he claims that the confusion caused by the telephone calls and the expenses of the lawyer he retained demonstrates that he suffered concrete prejudice.
The Sixth Circuit observed that in TransUnion LLC v. Ramirez, the United States Supreme Court recently clarified what is required to demonstrate that a violation of a procedural right has established concrete harm and, therefore, the plaintiff “must demonstrate either that the procedural harm itself is tangible harm of the kind traditionally recognized or that procedural violations have caused independent tangible harm. After conducting this investigation here, the Sixth Circuit concluded that the consumer did not have standing to pursue his alleged Article III claims.
As a result of the alleged violations of the FDCPA, the consumer argued that the FDCPA created an enforceable right to know who is calling about a debt because the defendant’s failure to correctly provide their full legal name caused them to concrete damage. The consumer further argued that this harm is closely related to the invasion of privacy that most states recognize.
The Sixth Circuit rejected the consumer’s argument because the defendant’s alleged failure to disclose his full legal name does not resemble traditional prejudice “considered to provide a basis for legal action”, as required to establish prejudice. concrete.
The Sixth Circuit recognized that most states recognize actions aimed at upholding the right to privacy, including “the offense of trespassing on the right to seclusion.” However, the Court noted that not receiving full and complete information about a defendant’s name does not closely resemble the trespassing offense, as this common law trespass usually requires proof. that the defendant “intentionally intruded[d], physically or otherwise, about another’s loneliness or isolation or their privacy affairs or concerns. “
The alleged harm to the consumer did not affect his privacy. Instead, it just confused him. The defendant did not share his private information with any third party or make his private information public. Thus, the Sixth Circuit concluded that the harm alleged by the consumer was “not closely related to traditional harm” and that the consumer could not establish a position based solely on the alleged violations of the law.
The consumer put forward several additional reasons for which he suffered concrete harm as a result of the alleged violation of the law. First, the consumer claimed that the defendant’s failure to properly identify himself in phone calls confused him and caused him to send a cease and desist request to the wrong entity. The Sixth Circuit rejected this argument because confusion in itself does not establish “concrete injury for the purposes of Article III”.
The consumer then argued that he had retained the services of a lawyer to stop the calls and that this action constituted tangible harm resulting from the violation of the law. The Sixth Circuit disagreed that the cost of hiring a lawyer establishes tangible harm, as applying this “logic to any claimant who hires a lawyer to positively pursue a claim would nullify the claims. limits created under Article III “.
Finally, the consumer argued that an additional call he received after sending his cease and desist letter to the wrong entity actually caused him harm. The Sixth Circuit declined to consider this argument because the consumer did not clearly allege in his complaint that he received another phone call after the cease and desist letter was sent or that this additional call to him. had caused harm.
Thus, the Sixth Circuit ruled that the consumer had not demonstrated that he had suffered “more than a simple procedural violation of the FDCPA” and that he had no standing to assert his claims under the Article III. Therefore, the Sixth Circuit overturned the trial court’s order granting summary judgment and remitted the case to be dismissed without prejudice for lack of jurisdiction in the matter.
Nutrition, indigenous methods and knowing where your fish comes from.
This multimedia message forms the link of a new partnership between the Bristol Bay Native Corporation, the salmon fishermen and Bambino’s Baby Food of Anchorage.
Bambino’s launched the country’s first subscription service with home delivery of frozen baby food in 2015, and was the first to bring the frozen option to the baby food retail aisles in the United States. United (without seafood).
Wild Alaskan seafood has always been a focus of Bambino’s menu since the launch of its baby-sized star-shaped halibut portions, bisque and sockeye salmon fillets in 2015. Sockeye Salmon Teething Strips are the newest addition. These items became an instant hit and are being shipped to customers all over the United States and Canada.
Each outlet box now contains recipes from the people of Bristol Bay, stories about how country foods are rooted in Alaskan culture, and other information about the area provided by the new Outreach Network.
“We look forward to partnering with Bambino’s and BBRSDA to share the stories about why salmon is so crucial to our region and our shareholders,” said Jason Metrokin, President and CEO of BBNC. “Salmon is a fundamental part of our cultures and values, from protecting the waters in which they spawn to ensuring that our shareholders are able to fill their freezers every year. “
“We want to make sure that people of all ages and all ages not only enjoy the nutritional benefits of Bristol Bay sockeye, but are also aware of the origin and sustainability of the region,” said Lilani Dunn. , Marketing Director of BBRSDA, operated and funded by the fleet of nearly 1,800 driftnet fishermen through a 1% tax on their catch.
“Bambino’s really built their business and their brand and it was no secret that their sockeye product was performing very well. And we saw a huge opportunity to tell our stories by focusing on the native families and culture of Bristol Bay and for ourselves in the marketing program, ”said Dunn. “I am very passionate, along with our partners, about the nutritional benefits of sockeye salmon, especially in young infants and toddlers. “
“The magnificent nature of it all is that we all care about our environment, the health and well-being of our families, and we all want to know where our food comes from,” said Zoi Maroudas, Founder and CEO by Bambino.
“It brings a lot of depth to the Bristol Bay region to have the synergy between BBNC and ourselves and to work with a company from Alaska,” added Dunn of BBRSDA. “It’s definitely something special and I’m really excited for it.”
[Anchorage baby food maker opens factory outlet in Spenard]
Bambino’s was selected as 2018 Alaska Manufacturer of the Year. All of its products are made in Anchorage and can be found at Safeway / Carrs and other grocery stores in South Central Alaska and on Amazon.
Good news for the sea creatures of GOA!
The results of the most detailed long-term cruise conducted by researchers at the University of Alaska / Fairbanks showed the highest concentrations of phytoplankton ever seen in nearly 25 years of sampling across a large part of the Gulf of Alaska. Phytoplankton (microalgae) are the basis of marine food webs and massive blooms were observed from May to September along the Seward Line, a study station transect that begins at the mouth of Resurrection Bay and continues south to the outer edge of the continental shelf. A financial boost from the National Science Foundation (NSF) added additional lines from the Copper River beyond Middleton Island, and from Kodiak’s Albatross Bank to the offshore waters.
Researchers are using chlorophyll, the green pigment found in plants, as an indicator of phytoplankton abundance, said Russ Hopcroft, professor and chair of the Department of Oceanography at the College of Fisheries and Ocean Sciences at UAF.
“It’s the peak of production in this system that kind of all of the biology of the Gulf stems from, this great infusion of energy and matter,” Hopcroft said. “Normally, the type of plateau lights up briefly and sporadically in terms of the concentration of algae. But last year the entire shelf was lit with a high chlorophyll content for several weeks continuously, which means there should have been plenty of food available for things that feed on plankton, fish. which feed on it, then the larger fish. , the marine mammals and seabirds that use them. We have never seen this kind of concentration of phytoplankton in the system.
“In the Gulf, because it is a very seasonal environment, several of the main species depend on this bloom to grow quickly and store fat in their bodies, just like bears,” he added. “And then they go down deep into the ocean to wait until the next spring to begin their life cycle when they lay eggs. And these babies come up to the surface and start the whole process over again.”
Cooler Alaskan weather this spring and summer can lead to prolonged blooms, and additional rains provide fresh water to the ocean surface that helps phytoplankton stay closer to the light and accumulate. higher concentrations.
Hopcroft said this year “it looks like it should translate into a lot of energy in the system” and hopefully allow a few things to bounce back that were hit by the extreme marine heat wave several years ago. years that caused, for example, the collapse of Gulf cod stocks. .
“I think we expect the success of animals released into the Gulf system this year to be higher than what we’ve seen during some of these warmer times,” he said. “One would hope that this would result in the recruitment of various types of fisheries over the next two years. “
Fake Fish Update
Long John Silver’s is the first major national seafood chain to put plant-based seafood analogues on its menu, and calls it the “next big wave” after seeing the success of hamburgers and chicken at herbal. Analogs are manufactured substances that are used in place of the real thing.
Last month, the company, operating more than 700 restaurants in the United States, announced a partnership with Good Catch to test their Fishless Breaded Fish Fillet and Plant-Based Breaded Crabless Cake at restaurants in California and Georgia.
“Our plant-based options are slightly more expensive than the crab cakes and the sustainably sourced wild cod, pollock and salmon that are our main menu options,” said Stephanie Mattingly, LJS Marketing Manager. SeafoodSource, adding that the plant-based seafood market is expected to grow by $ 1.3 billion over the next decade.
Amazon-owned Whole Foods Market said nearly half of U.S. consumers are looking for plant-based products and alternatives to fish are on its very first list of trend forecasts.
One is Banana Blossom Upton’s Naturalslarge, purple-skinned flowers that grow after a bunch of bananas. Their neutral flavor and flaky texture make them an ideal fish substitute. Another expected favorite is Good Catch Fishless Tuna, composed of a mixture of peas, chickpeas, lentils, soybeans, beans and white beans.
Samuels and Son Seafood of Philadelphia is the first company to publicly admit that he sells genetically modified Atlantic salmon manufactured by AquaBounty Technologies of Massachusetts. The wholesale restaurant supplier serves several chains, including McCormick and Schmicks, Morton’s Steakhouse and The Hard Rock Café.
Fish, which grow about three times faster than normal salmon, are the first genetically modified animal to be approved by the federal government for human consumption. More than 80 food companies, including Safeway, Kroger, Trader Joe’s and Whole Foods, have said they will refuse to transport it.
Federal labeling law “directs” companies to disclose genetically modified ingredients by means of a QR code, packaging wording or symbol. Mandatory compliance takes effect in January 2022, but the rules do not apply to restaurants or out-of-home meal providers.
NEW YORK, 23 Aug 2021 / PRNewswire / – The Jordan Company, LP (“TJC”) is pleased to announce the successful closing of The Resolute II Continuation Fund, LP (and its associated vehicles, the “Fund”). The Fund is made up of more than $ 10.3 billion in capital commitments, which financed the purchase of portfolio companies from The Resolute Fund II, LP (“Resolute II”), a 2007 vintage fund with approximately $ 30.6 billion in capital commitments, and is the first continuation fund established by TJC.
The Fund provides TJC with additional time and capital to support the continued growth of key portfolio assets, while providing Resolute II limited partners with an attractive liquidity opportunity to solidify their returns.
“With the closing of the Fund, we are delighted to expand our partnership with the Fund’s portfolio companies while providing existing Limited Partners of Resolute II the ability to receive cash based on their individual investment objectives,” said Rich Caputo, Managing Partner of TJC. “The transaction received strong support from existing sponsors of Resolute II and was oversubscribed by potential new investors. We could not be more satisfied with the high quality investor base that the Fund has attracted ”, added Kristin custar, partner and head of TJC’s Global Investor Capital Group.
The companies in the Fund’s portfolio are representative of TJC’s long-standing focus on investing in mid-market companies with strong potential for cash flow conversion and operational improvement in fragmented markets across all four sectors. Major Company Verticals: Consumer and Healthcare; Industrialists; Technology, telecommunications and utilities; and Transport & Logistics.
“We believe this transaction strengthens the alignment between the management teams of the Fund’s portfolio companies, the limited partners and TJC. We are delighted to begin a new chapter in our partnership with our investors and our management ”, added Rich Caputo.
The transaction was led by Hamilton Lane and included a diverse group of secondary and primary investors, including the limited partners of Resolute II. TJC has offered all existing Resolute II limited partners the opportunity to exercise a full liquidity option, a rollover option and an option to seek to make additional capital commitments to the Fund.
M2O Private Fund Advisors served as exclusive financial advisor to TJC and Latham & Watkins served as legal advisor to TJC. Ropes & Gray acted as legal counsel for Hamilton Lane.
About Jordan Company TJC, founded in 1982, is a mid-sized private equity firm managing funds with initial capital commitments exceeding $ 16 billion since 1987 and 39 years of experience in investing and contributing to growth. many companies in a wide range of industries, including consumer and healthcare; Industrialists; Technology, telecommunications and utilities; and Transport & Logistics. The senior investment team have been investing together for over 20 years and are supported by the Operations Management Group, which was established in 1988 to initiate and support operational improvements in portfolio companies. Based in New York, TJC also has offices in Chicago and Stamford. For more information, please visit www.thejordancompany.com.
About Hamilton Lane Hamilton Lane (NASDAQ: HLNE) is a leading private markets investment management firm providing innovative solutions to sophisticated investors around the world. Dedicated exclusively to private markets investing for 30 years, the firm currently employs around 475 professionals operating in offices across North America, Europe, Asia Pacific, and the Middle East. Hamilton Lane has $ 757 billion in assets under management and supervision, including $ 92 billion in discretionary assets and $ 665 billion in advisory assets, as of June 30, 2021. Hamilton Lane specializes in creating investment programs. ‘flexible investments that provide clients with access to the full range of private market strategies, sectors and geographies. For more information, please visit www.hamiltonlane.com or follow Hamilton Lane on LinkedIn: www.linkedin.com/company/hamilton-lane.